Tempest Therapeutics Financial Overview
Tempest Therapeutics's market cap is currently $14.44M. The company's EPS TTM is $-0.79; its P/E ratio is -0.29; Tempest Therapeutics is scheduled to report earnings on November 5, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
